Carlos

AOL Sells Patents To Microsoft

Post author:Carlos
Post published:April 10, 2012
Post category:Financing
Post comments:0 Comments

AOL sells patents to Microsoft. Why? The reasons for AOL selling these patents are pretty clear: Shares of AOL surged as much as 45% Monday, hitting their highest point in…

Flamel – Eclat and NicOx – Altacor: What can we learn?

Post author:Carlos
Post published:March 21, 2012
Post category:Biotech Drug Delivery
Post comments:0 Comments

The past seven days have brought us two very interesting transactions. First, on March 14, Lyon-based Flamel announced their acquisition of St. Louis-based Eclat Pharmaceuticals. The press release contains a…

Pfizer Biocon signals the end for biosimilars? Hardly…

Post author:Carlos
Post published:March 15, 2012
Post category:Biotech Emerging Markets Government India
Post comments:0 Comments

Earlier this week we learned that Pfizer will return to Biocon rights to biosimilar versions of various insulin derivatives: As of March 12, 2012, all rights licensed to Pfizer will…

Burrill Speaks, We Agree

Post author:Carlos
Post published:February 21, 2012
Post category:Drug Development Entrepreneurship Venture Capital
Post comments:1 Comment

The February, 2012 issue of Life Science Leader has a wide-ranging interview with G. Steven Burrill. It's an interesting, insightful read, and we can recommend the interview. Mr. Burrill makes…

Biosimilar product development guidelines

Post author:Carlos
Post published:February 10, 2012
Post category:Biotech Drug Development
Post comments:0 Comments

UPDATE (21 February) - Here is a decent video interview of Rachel Sherman, head of the Office of Medical Policy for the FDA, on the Biosimilar guidelines: BioCentury This Week Today…

Tau Wins…Sort Of

Post author:Carlos
Post published:February 7, 2012
Post category:Drug Development
Post comments:0 Comments

Last week, the NY Times published an interesting article on the cause of Alzheimer's Disease. The article describes experiments in a new mouse model which may confirm, once and for…

JP Morgan Healthcare Conference – The #JPM12 Edition

Post author:Carlos
Post published:January 13, 2012
Post category:Conferences
Post comments:0 Comments

Lacerta Bio has returned to cold, windy New York following a solid week in sunny, warm San Francisco. We blogged about last year's JP Morgan Healthcare conference here . For…

Happy Birthday, Lacerta Bio!

Post author:Carlos
Post published:January 4, 2012
Post category:Uncategorized
Post comments:0 Comments

Last month, Lacerta Bio celebrated its first full year in existence. In fact, our coming out event was JP Morgan 2011. What have we learned in a year? Probably too…

JP Morgan Kicks off 2012

Post author:Carlos
Post published:January 3, 2012
Post category:Conferences
Post comments:1 Comment

Happy New Year, everyone! Next week, 2012 kicks off with the madness otherwise knows as JP Morgan, or #JPM12 if you prefer. We blogged about last year's conference here. Last…

JP Morgan Healthcare Conference 2012

Post author:Carlos
Post published:December 15, 2011
Post category:Conferences
Post comments:0 Comments

We are busy preparing for the Annual Industry kickoff conference at the Westin in San Francisco. Currently, we are scheduling 30-minute meetings on behalf of our clients. Plus, we're planning…

Get in touch